Your browser doesn't support javascript.
loading
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Cabasag, Citadel J; Arnold, Melina; Rutherford, Mark; Ferlay, Jacques; Bardot, Aude; Morgan, Eileen; Butler, John; O'Connell, Dianne L; Nelson, Gregg; Høgdall, Claus; Schnack, Tine; Gavin, Anna; Elwood, Mark; Hanna, Louise; Gourley, Charlie; De, Prithwish; Saint-Jacques, Nathalie; Mørch, Lina Steinrud; Woods, Ryan R; Altman, Alon D; Sykes, Peter; Cohen, Paul A; McNally, Orla; Møller, Bjørn; Walsh, Paul; Morrison, David S; Bray, Freddie; Soerjomataram, Isabelle.
Afiliação
  • Cabasag CJ; International Agency for Research on Cancer, Lyon, France.
  • Arnold M; International Agency for Research on Cancer, Lyon, France.
  • Rutherford M; International Agency for Research on Cancer, Lyon, France.
  • Ferlay J; Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK.
  • Bardot A; International Agency for Research on Cancer, Lyon, France.
  • Morgan E; International Agency for Research on Cancer, Lyon, France.
  • Butler J; International Agency for Research on Cancer, Lyon, France.
  • O'Connell DL; Northern Ireland Cancer Registry, Center for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Nelson G; Royal Marsden Hospital, London, England, UK.
  • Høgdall C; The Daffodil Center, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.
  • Schnack T; Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada.
  • Gavin A; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Elwood M; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hanna L; Odense University Hospital, Odense, Denmark.
  • Gourley C; Northern Ireland Cancer Registry, Center for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • De P; Department of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.
  • Saint-Jacques N; Velindre Cancer Center, Cardiff, Wales, UK.
  • Mørch LS; Institute of Genetics and Cancer, Cancer Research UK Edinburgh Center, The University of Edinburgh, Edinburgh, Scotland, UK.
  • Woods RR; Ontario Health, Toronto, Canada.
  • Altman AD; Nova Scotia Health Cancer Care Program, Halifax, Nova Scotia, Canada.
  • Sykes P; The Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark.
  • Cohen PA; Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.
  • McNally O; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Manitoba, Canada.
  • Møller B; CancerCare Manitoba Research Institute, Manitoba, Canada.
  • Walsh P; University of Otago, Christchurch, New Zealand.
  • Morrison DS; Department of Gynaecological Oncology, St John of God Subiaco Hospital, Perth, Western Australia, Australia.
  • Bray F; Discipline of Obstetrics and Gynaecology, Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Soerjomataram I; Royal Women's Hospital, Melbourne, Australia.
Int J Cancer ; 152(9): 1763-1777, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36533660
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline / Incidence_studies / Risk_factors_studies Limite: Aged / Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline / Incidence_studies / Risk_factors_studies Limite: Aged / Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article